Although it is known that MAP4K4 functions through MAPK pathways, including JNK 1/2, ERK 1/2, and p38, it remains unclear which of the MAPK pathways is activated by MAP4K4 in cancer. This evidence concerns the gene MAP4K4 and cancer.